Back to Search
Start Over
Characterisation of the nasal microbiota in granulomatosis with polyangiitis.
- Source :
-
Annals of the rheumatic diseases [Ann Rheum Dis] 2018 Oct; Vol. 77 (10), pp. 1448-1453. Date of Electronic Publication: 2018 Jul 11. - Publication Year :
- 2018
-
Abstract
- Objectives: Prior studies have suggested a potential link between nasal microbes and granulomatosis with polyangiitis (GPA; Wegener's), but these studies relied on culture-dependent methods. This study comprehensively examined the entire community of nasal microbiota (bacteria and fungi) in participants with GPA compared with healthy controls using deep sequencing methods.<br />Methods: 16S rRNA and internal transcribed spacer gene sequencing were performed on nasal microbial DNA isolated from nasal swabs of 60 participants with GPA and 41 healthy controls. Alpha and beta diversity were assessed as well as the relative abundance of the most abundant bacterial and fungal taxa. The effects of covariates including disease activity and immunosuppressive therapies on microbial composition were evaluated.<br />Results: Compared with controls, participants with GPA had a significantly different microbial composition (weighted UniFrac p=0.04) and lower relative abundance of Propionibacterium acnes and Staphylococcus epidermidis (for both, false discovery rate-corrected p=0.02). Disease activity in GPA was associated with a lower abundance of fungal order Malasseziales compared with participants with GPA in remission (p=0.04) and controls (p=0.01). Use of non-glucocorticoid immunosuppressive therapy was associated with 'healthy' nasal microbiota while participants with GPA who were off immunosuppressive therapy had more dysbiosis (weighted UniFrac p=0.01). No difference in the relative abundance of Staphylococcus aureus was observed between GPA and controls.<br />Conclusions: GPA is associated with an altered nasal microbial composition, at both the bacterial and fungal levels. Use of immunosuppressive therapies and disease remission are associated with healthy microbial communities.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.)
- Subjects :
- Adult
Aged
Female
Granulomatosis with Polyangiitis drug therapy
Humans
Immunosuppressive Agents therapeutic use
Malassezia isolation & purification
Male
Middle Aged
Propionibacterium isolation & purification
RNA, Ribosomal, 16S
Staphylococcus epidermidis isolation & purification
DNA, Bacterial isolation & purification
DNA, Fungal isolation & purification
Granulomatosis with Polyangiitis microbiology
Microbiota
Nasal Cavity microbiology
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2060
- Volume :
- 77
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Annals of the rheumatic diseases
- Publication Type :
- Academic Journal
- Accession number :
- 29997110
- Full Text :
- https://doi.org/10.1136/annrheumdis-2018-213645